Parlaying Pearls of Experiential Education
Experiential Education Directors, Ohio Colleges of Pharmacy
This session is intended for pharmacists who train students during their introductory pharmacy practice experience or advanced pharmacy practice experience. During this session experiential directors will provide experiential development for current and future preceptors.
Piecing Together Insulin Pump Therapy and the Role of a Pharmacist
Melody L. Hartzler, PharmD, BCACP, BC-ADM, Clinical Pharmacist & Chronic Care Coordinator and Samantha Yates, PharmD, PGY1 Community Pharmacy Resident, Western Medicine, Inc.; Kevin Kelleher, BSN, RN, CDE, Sr. Clinical Territory Manager, Medtronic Diabetes
This session will discuss the evidence behind the use of insulin pump therapy and continuous glucose monitoring systems to improve diabetes care. The reimbursement model and economic impact will also be discussed. Pharmacists will leave with clinical pearls for managing patients on insulin pump therapy, as well as tips on working with patients during the dispensing process.
Partnering with Ohio’s Area Agencies on Aging to Serve Your Older Adult Patients
Julie Trackler, Chief, Elder Connections Division, Ohio Department of Aging; Duana Patton, CEO, Ohio District 5 Area Agency on Aging; Jacquelyn Bradley, Director, Area Agency on Aging 3
Ohio’s 60+ population, the largest consumers of prescription drugs, is expected to grow by 25% by 2020 and will double by 2040. Pharmacists, as a trusted source of health information, receive questions regarding a broad array of older adult concerns, such as finding reliable home care services, signing up for home-delivered meals and getting a ride to the doctor. This session will include information on how pharmacists can work with Ohio’s area agencies on aging (AAAs) to meet the needs of older adults. Our speakers will also discuss how pharmacists can identify and report suspected elder abuse.
The Journey of Recovery from Addiction
Phyllis A. Grauer, PharmD, BCGP, CPE, CDCA, Charxis Consulting, LLC
Addiction is a family disease. Negotiating treatment and recovery is a roller coaster ride. This program highlights the struggles and victories of dealing with the life-long journey of recovery through the eyes of the recovering addict.
2019 OTC and Self-Care Challenge
Moderators: Kristine Mason, PharmD, PGY2/MS Community-based Pharmacy Administration and Leadership resident, OSU and Kroger Health & Wellness; and Brianne Porter, PharmD, MS, Assistant Professor – Practice, The Ohio State University College of Pharmacy
Learn up-to-date information about nonprescription products, along with the rationale for product choices, at OPA’s 13th annual “OTC and Self-Care Challenge – Battle of the Colleges!” Join us for a highly interactive, fun-filled session that will enhance your OTC expertise and update your knowledge of common self-care conditions.
Supported by NASPA, AACP and the Non-prescription Medicines Academy
Future Trends and Technologies in Pharmacy
Adam Chesler, PharmD, Director, Regulatory Affairs, Cardinal Health
The practice of pharmacy is changing at a rapid rate; new trends and technologies are understood to be part of the future of our profession. Even though these technologies are accepted as the future, most people do not truly know what implementation of them will look like. Our speaker will discuss these new trends and technologies, as well as potential roadblocks to consider while these technologies advance toward reality.
Ohio Comprehensive Primary Care (CPC): A Value-Based Opportunity for Pharmacists
Stuart Beatty, PharmD, Associate Professor of Clinical Pharmacy, OSU College of Pharmacy; Marjorie Yano, Payment Innovation Director and Mylynda Drake, Comprehensive Primary Care Program Administrator, Ohio Department of Medicaid; Phillip Farwig, PharmD and Jennifer Sabatino, PharmD, Specialty Practice Pharmacists, The Ohio State University Physicians, Inc.
This session will discuss the Ohio Comprehensive Primary Care (CPC) program. Attendees will learn details about the program, ways to identify practices enrolled in the program, and opportunities for pharmacists to interface with Ohio CPC practices. Examples of pharmacist interventions that are improving CPC clinical metrics will be shared.
Innovative Approaches to Change Opioid Prescribing Practices and Improve Patient Engagement in Care
Aleda M. H. Chen, PharmD, PhD, Assistant Dean and Associate Professor; Marc Sweeney, PharmD, Dean and Professor; Cedarville University School of Pharmacy
How do we engage stakeholders - prescribers and patients - to move toward best practices in pain management? How do we overcome barriers that seem to prevent us from meaningful change? This session will briefly highlight the CDC 2016 chronic pain management guidelines and provide panel perspectives on initiatives in Ohio to address pain management and opioid use. Participants, in a workshop-style format, will actively identify barriers to engagement and change in the area of opioids and work on solutions.
Angina Pectoris: Understanding the Heart of the Pain (repeated at 2:40 p.m.)
Vincent F. Mauro, RPh, PharmD, FCC, Professor of Clinical Pharmacy
The University of Toledo College of Pharmacy and Pharmaceutical Sciences
This session will discuss an overview of angina, its etiology, pathogenesis, and pharmacotherapy. Discussion will include important clinical aspects and issues relevant to the medications used to treat patients with angina. Cases studies will be utilized to stress important clinical perspectives.
Ohio Research Forum 2019
Moderator: Timothy R. Ulbrich, PharmD, Clinical Professor of Pharmacy and Program Director, MS – Health-System Pharmacy Administration; OSU College of Pharmacy
Research conducted by Ohio pharmacists, college faculty, pharmacy residents and/or students will be showcased in the annual Ohio Research Forum. Research areas may include those from pharmacy practice, scientific research, economic/social/administrative sciences, and pharmacy education. The Poster Session will open at 4:10 p.m. inside the Exhibit Hall.
Details on DOACs: Indications, Monitoring, Adherence, and More!
Heather A. Johnson, PharmD; E. Michael Murphy, PharmD; PGY1 Pharmacy Residents, Ambulatory Care, OSU College of Pharmacy
This session will include a review of the pharmacology of direct oral anticoagulants (DOACs), common adverse events, approved indications and dosing. The activity will explore best practices for monitoring of DOACs including recommended labs and frequency. New findings regarding adherence to DOACs reversal agents will also be reviewed.
Strategies to Improve Patient Health Through Pharmacist-Provided Care
Micah Cost, PharmD, MS, Executive Director, Tennessee Pharmacists Association
2:40 p.m. (CPE Credit/Program: 0.15 CEU)
Payment for pharmacist services through medical provider credentialing and contracting is critical. You will learn how pharmacists in Tennessee have moved forward in receiving payment for services in a variety of different payment models. The speaker will share practical ideas that can be replicated in Ohio to move forward in this important area.
Angina Pectoris: Understanding the Heart of the Pain (repeat of 1:00 p.m. program)
Ohio Innovative Practice Forum 2019
Moderators: Jennifer Rodis, PharmD, BCPS, FAPhA, Clinical Associate Professor of Pharmacy and Assistant Dean for Outreach and Engagement and Timothy R. Ulbrich, PharmD, Clinical Professor of Pharmacy and Program Director, MS – Health-System Pharmacy Administration; OSU College of Pharmacy
Innovative pharmacy practices and services in Ohio will be showcased to help pharmacists initiate or expand novel services and approaches in their own practices. Practitioners from a variety of practice sites will present examples, and share successful implementation strategies and methods for overcoming barriers to offer patient-centered services.
Side Effects: The Story Behind the Story of Ohio’s PBM Upheaval
Eric Pachman, MBA, Drug Pricing Researcher, 46brooklyn Research; Darrel Rowland, Public Affairs Editor; Cathy Candisky and Marty Schladen, Public Affairs Reporters; and Lucas Sullivan, Special Projects Reporter, Columbus Dispatch
2018 was a pivotal year for Ohio revamping its dealings with pharmacy benefit managers (PBMs), throwing out the old spread pricing model, and adding sweeping new requirements for transparency and accountability. The Columbus Dispatch wrote more than five dozen stories, using computer analysis to demonstrate how PBMs used spread pricing to charge the state higher amounts than they reimbursed pharmacies. Speaker Eric Pachman provided crucial analysis that not only aided the newspaper's effort, but helped convince lawmakers that change was needed. In this session, Pachman and Dispatch reporters will highlight "the story behind the story" and the public data work and reporting that has led to reform.
Clostridium difficile Infection: Scope of Disease and Updates to Treatment
Andrew M. Roecker, PharmD, R.Ph., BCPS, Professor and Chair, Department of Pharmacy Practice and Director of Continuing Education, Raabe College of Pharmacy, Ohio Northern University
Clostridium difficile is the most commonly identified source of infectious diarrhea in healthcare settings. Disease incidence and mortality from Clostridium difficile infection (CDI) have continued to increase, especially in elderly patients and those exposed to antimicrobial agents. This program will discuss the issues associated with CDI and recommended treatment strategies, both pharmacologic and non-pharmacologic, for CDI eradication given the updated guidelines from 2018.
Pharmacy Law Update 2019 (repeated at 9:55 a.m.)
Sheri Zapadka, R.Ph., Compliance Specialist; State of Ohio Board of Pharmacy
Our speaker will present information regarding changes to Ohio laws/rules in the last year, and will review commonly asked questions about opioid prescriptions, technician registration, medical marijuana and more. This session is a must for all pharmacists who want to stay up-to-date on legislative and regulatory changes impacting the practice of pharmacy.
This program qualifies for State of Ohio Board of Pharmacy jurisprudence CPE credit.
Approaches to Acute and Chronic Pain in Patients with Addictive Disease
Theodore Parran, Jr., MD, Isabel and Carter Wang Professor and Chair in Medical Education, Case Western Reserve University School of Medicine
Approaches to acute and chronic pain management are rapidly evolving in medical practice. This is especially true in the sub-group of patients with prior or current substance use disorders. This workshop will focus on evolution of prevailing practices regarding acute and chronic pain management; the pharmacology of controlled drugs; the phenomenon of prescription drug abuse; and application of these concepts to general strategies for the management of patients with substance abuse problems who have acute and chronic pain issues.
An Ounce of Prevention: Pharmacist Provision of Clinical Preventive Services
Natalie DiPietro Mager, PharmD, MPH, Associate Professor of Pharmacy Practice, ONU College of Pharmacy
According to a recent article in Health Affairs, only 8% of adults in the U.S. 35 years and older had received all of the recommended clinical preventive services in 2015. Pharmacists are well-positioned to close this gap, either through the direct provision of services or referrals. This session will review evidence-based recommendations for clinical preventive services from the U.S. Preventive Services Task Force, apply recommendations to patient cases, and provide practice considerations for pharmacists. ACPE #0129-0000-19-036-L04-P
Outcomes-based Technology – Empowering Pharmacists and Helping Patients
Perry Lewis, Vice President of Industry Relations, CoverMyMeds
As the role of pharmacists in patient care expands, technological innovations to streamline administrative processes and workflows are more important than ever and will be the focus of this presentation. Electronic prior authorization (ePA) increases efficiency at the pharmacy while securing time- and cost-savings. Complete value of ePA is accessed when used prospectively and with real-time benefit check (RTBC) solutions, which can inform providers and patients about insurance coverage, PA requirement, on-formulary alternatives, possibility of patient-assistance programs and even cash price. As 9 of 10 top-selling drugs will be specialty by 2020, use of such technologies to navigate the complicated specialty process will be imperative.
Leadership Throughout Your Career
Moderator: Jennifer Sabatino, PharmD, R.Ph., BCACP, Clinical Pharmacist at OSU General Internal Medicine; and Panel of Pharmacist Leaders
A panel of pharmacists from a variety of practice backgrounds and in various stages of their career will share their experiences being called to leadership. They will share the challenges they are facing as leaders in the profession and how they are working to overcome these challenges. Panelists will offer advice on how to prepare for one’s call to leadership, as well as resources to utilize along the way.
Pharmacy Law Update 2019 (repeat of 8:15 a.m. program)
Best Practices in Medication Assisted Opioid Treatment
Theodore Parran, Jr., MD, Isabel and Carter Wang Professor and Chair in Medical Education, CWRU School of Medicine
Medication assisted treatment (MAT) is an area of opioid addiction treatment that has undergone great change in the past 15 years. Methadone maintenance through Opiate Treatment Programs, oral and injectable naltrexone, sublingual buccal and depot injectable buprenorphine are all being used in patient management. This session will review the major families of MAT - methadone, buprenorphine and naltrexone - as well as advantages of different formulations and delivery systems. Best practices in the integration of MAT into sobriety-focused treatment as well as harm reduction treatment will be reviewed.
Implementing Medical Marijuana Education into Existing Patient Centered Care Practices
Jessica Hinson, PharmD, BCACP, NCTTP, Assistant Professor of Pharmacy Practice and Pharmacist, ONU HealthWise Pharmacy; Amber Williams, PharmD Candidate; ONU College of Pharmacy
With implementation of HB 523 there is the potential for a gap in patient care due to strict recommendation parameters for approved cannabinoid based drugs and marijuana still federally classed as a CI substance. This session is designed to provide pharmacists, in all practicing capacities, with the knowledge and tools needed to assess appropriate use of medications and maintain patient centered care standards.
Immunization Update 2019
Donald L. Bennett, R.Ph., MBA, Clinical Assistant Professor, OSU College of Pharmacy
This presentation will review identified trends in vaccine-preventable disease prevalence and recent changes in recommendations from CDC’s Advisory Committee on Immunization Practices. The impact of the 2018-2019 influenza season will be discussed, as well as recent trends in vaccine-related medication errors.
Innovative Pharmacy Business Plan Competition 2019
In this annual competition, students have been invited to submit business plans detailing the loan request, mission statement, detailed description of the business, marketing plan and financial reports for buying a pharmacy or developing innovative pharmacy services. Three finalist teams will present their plans to a panel of judges. Hear what the students envision for the future of pharmacy and get ideas for your own practice.
Sponsored by Cardinal Health
Pharmacy Technician Full Scope of Practice: Evidence > Emotions
Deeb D. Eid, PharmD, Assistant Professor/Experiential Coordinator at Ferris State College of Pharmacy
This session aims to relinquish the perspective of “advancing or evolving scope of practice” and start conversations about “full scope of practice” for pharmacy technicians. A designed “litmus test” analysis will cover evidence, laws, and education/training to better propose a way to forge ahead by placing more weight on evidence than emotions. The audience can take ideas from other practice models, work together to craft better legislation, and ultimately work to a goal for “full scope of practice” of the pharmacy technician to better complement the role of the pharmacist.
Making a Difference for Individuals with Cancer and Their Caregivers
Bethanne Brown, PharmD, BCACP, Associate Professor; Rowena Schwartz, PharmD, BCOP, Associate Professor; Jenelle Sobotka, PharmD, Professor; Winkle College of Pharmacy University of Cincinnati
This session will look at the evolution of cancer care and the important role of the pharmacist in optimizing care. Three pharmacists will share their own experience with cancer and describe opportunities for pharmacy to optimize care from diagnosis to survivorship. Participants will leave this interactive discussion with a better understanding of where our profession can and does make an impact while identifying resources available for patients, caregivers and providers.
START, STOPP or Beers? How to Move Toward Safe Medication Use in Older Adults
Ruth Emptage, R.Ph., PharmD, BCGP and Zach Woods, R.Ph., PharmD; Assistant Professors – Practice, OSU College of Pharmacy
Potentially inappropriate medication use can lead to significant patient harm, especially in older adults. Pharmacists, with their knowledge of medications, are uniquely prepared to keep patients safe through the elimination or mitigation of injury caused by healthcare errors. By utilizing medication-focused patient scenarios, the presenters will showcase the useful criteria available to guide decisions regarding medication use in older adults. Active learning techniques will encourage participants to utilize tools such as the START/STOPP and updated Beers criteria to help maximize safe medication use in older adults.
This program qualifies for State of Ohio Board of Pharmacy patient/medication safety CPE credit.
Optimizing Personal and Organizational Well-Being to Decrease Professional Burnout: An Evidence-based Primer for Pharmacists!
Bernadette Melnyk, PhD, RN, APRN-CNP, FAANP, FNAP, FAAN
Chief Wellness Officer and Vice President for Health Promotion; Dean and Professor, College of Nursing; The Ohio State University
Burnout is common among health care workers and is characterized by emotional exhaustion that results in depersonalization and decreased personal accomplishment at work. This presentation will focus on evidence-based strategies to enhance personal and professional well-being in pharmacists. Strategies for building and sustaining organizational wellness cultures that yield a high rate of return on investment and value of investment will be highlighted.
Pharmacogenomics: An Introduction to an Opportunity
Sue Paul, R.Ph., Founder SyneRxgy Consulting, Co-Founder PGx101 and Medipreneurs;
Daniel Krinsky BS, MS, R.Ph., Professor, Department of Pharmacy Practice, NEOMED and Co-Founder PGx101; Amy Van Milligan, MD, Crossroad Health Center
Pharmacogenomic (PGx) testing can be used to more accurately predict a patient’s response to a given drug. Although use of this testing has been limited in many settings, opportunities exist for pharmacists to step into this exciting area of patient care. This presentation will include basic pharmacogenetic terms, concepts and evidence, and will address implementation of a pharmacogenomic testing service, its unique challenges, and case studies to illustrate how PGx data can improve patient care.
The Role of LDL Targets in the Updated ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol
Patricia Wigle, BCPS, BCACP, FCCP, Professor, Division of Pharmacy Practice and Administrative Sciences, UC College of Pharmacy
This session will discuss the clinical and pharmacotherapeutic implications related to the 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol. Case studies will be utilized to emphasize important pharmacotherapeutic perspectives.
New Drug Update 2019 (repeated at 9:55 a.m.)
Karen Kier, PhD, M.Sc., R.Ph., Professor of Clinical Pharmacy, Director of Assessment, ONU College of Pharmacy
New drug products that impact current therapy guidelines or are innovative approaches to current treatment are continually released to the market. This program will review the pharmacology and therapeutics of the prescription medications released in the past year, their indications, clinical applications, drug interactions, adverse effects and toxicities, and important patient counseling information.
Legislative Update 2019
Ernest Boyd, PharmD (Hon), CAE, and Antonio Ciaccia, OPA Lobbyist
The pharmacy profession is in the midst of rapid change: scope of practice advancements, drug pricing reform, reimbursement pressure, and many regulatory modifications. 2018 brought many changes and 2019 is shaping up to bring even more. This session will review recent legislative and regulatory changes from the previous year, and provide an essential update on the progress of pending and future advocacy initiatives. Come see what OPA is working on, and become part of the advocacy process.
Sponsored by Cleveland Clinic
New Drug Update 2019 (repeat of 8:15 a.m. program)
Diabetes in 2019: What’s New and on the Horizon?
Diana Isaacs, PharmD, BCPS, BC-ADM, CDE, Clinical Pharmacy Specialist and CGM Program Coordinator, Cleveland Clinic Endocrinology & Metabolism Institute Diabetes Center
This session will focus on diabetes management guideline updates, new therapies and medications likely to receive FDA approval this year, including sotagliflozin, oral semaglutide, new glucagon formulations, and dapagliflozin for type 1 diabetes.
Dispensing Naloxone 101: Get in Your Comfort Zone
Dana Wilkerson, PharmD, MS, System Ambulatory Pharmacy Manager, Pharmacy Systems Inc./Holzer Health System; Bella Mehta, PharmD, FAPhA, Professor of Clinical Pharmacy & Family Medicine, OSU College of Pharmacy; Kristine Mason, PharmD, PGY2/MS Community-based Pharmacy Administration and Leadership resident, OSU and Kroger Health & Wellness
In 2017, over 4,500 Ohioans died from an unintentional drug overdose with 85.7% of deaths being related to opioids. A target area for decreasing opioid-related overdose deaths is through the expansion of community access to naloxone. This session will describe areas of knowledge and comfort related to dispensing naloxone without a prescription for pharmacists and pharmacy interns in a community-based pharmacy setting. Attendees will practice ways to engage patients and community members to increase access to naloxone.
A Functional Medicine Approach to Dietary Supplements and Nutrition
Lauren Castle, PharmD, MS; Founder, Functional Medicine Pharmacists Alliance
The global dietary supplements market is expected to be valued at over $278 billion by 2024, and as the lines between food and medicine are blended, pharmacists are often asked for dietary supplement and nutrition recommendations. However, research suggests pharmacists' therapeutic knowledge of dietary supplements and nutrition appears to be poor. This presentation will provide a guided tour through a typical pharmacy's dietary supplement aisle to enhance pharmacists' capabilities to provide evidence-based recommendations to patients seeking an integrative, lifestyle, or functional medicine approach to their healthcare.